ABSTRACT
PURPOSE: The present investigation focuses on Skin Cutaneous Melanoma (SKCM), a melanocytic carcinoma characterized by marked aggression, significant heterogeneity, and a complex etiological background, factors which collectively contribute to the challenge in prognostic determinations. We defined a novel classifier system specifically tailored for SKCM based on multiomics. METHODS: We collected 423 SKCM samples with multi omics datasets to perform a consensus cluster analysis using 10 machine learning algorithms and verified in 2 independent cohorts. Clinical features, biological characteristics, immune infiltration pattern, therapeutic response and mutation landscape were compared between subtypes. RESULTS: Based on consensus clustering algorithms, we identified two Multi-Omics-Based-Cancer-Subtypes (MOCS) in SKCM in TCGA project and validated in GSE19234 and GSE65904 cohorts. MOCS2 emerged as a subtype with poor prognosis, characterized by a complex immune microenvironment, dysfunctional anti-tumor immune state, high cancer stemness index, and genomic instability. MOCS2 exhibited resistance to chemotherapy agents like erlotinib and sunitinib while sensitive to rapamycin, NSC87877, MG132, and FH355. Additionally, ELSPBP1 was identified as the target involving in glycolysis and M2 macrophage infiltration in SKCM. CONCLUSIONS: MOCS classification could stably predict prognosis of SKCM; patients with a high cancer stemness index combined with genomic instability may be predisposed to an immune exhaustion state.Communicated by Ramaswamy H. Sarma.
ABSTRACT
Osteoclasts are over-activated as we age, which results in bone loss. Src deficiency in mice leads to severe osteopetrosis due to a functional defect in osteoclasts, indicating that Src function is essential in osteoclasts. G-protein-coupled receptors (GPCRs) are the targets for â¼35% of approved drugs but it is still unclear how GPCRs regulate Src kinase activity. Here, we reveal that GPR54 activation by its natural ligand Kisspeptin-10 (Kp-10) causes Dusp18 to dephosphorylate Src at Tyr 416. Mechanistically, Gpr54 recruits both active Src and the Dusp18 phosphatase at its proline/arginine-rich motif in its C terminus. We show that Kp-10 binding to Gpr54 leads to the up-regulation of Dusp18. Kiss1, Gpr54 and Dusp18 knockout mice all exhibit osteoclast hyperactivation and bone loss, and Kp-10 abrogated bone loss by suppressing osteoclast activity in vivo. Therefore, Kp-10/Gpr54 is a promising therapeutic target to abrogate bone resorption by Dusp18-mediated Src dephosphorylation.
Subject(s)
Bone Resorption , Osteoclasts , Animals , Mice , Osteoclasts/metabolism , Kisspeptins/genetics , Kisspeptins/metabolism , Receptors, G-Protein-Coupled/metabolism , src-Family Kinases/genetics , src-Family Kinases/metabolism , Mice, Knockout , Bone Resorption/genetics , Receptors, Kisspeptin-1ABSTRACT
[This retracts the article DOI: 10.3892/ol.2018.8268.].
ABSTRACT
Lithium (Li) metal is a highly promising anode material for next-generation high-energy-density batteries, while Li dendrite growth and the unstable solid electrolyte interphase layer inhibit its commercialization. Herein, a chemically grafted hybrid dynamic network (CHDN) is rationally designed and synthesized by the 4,4'-thiobisbenzenamine cross-linked poly(poly(ethylene glycol) methyl ether methacrylate-r-glycidyl methacrylate) and (3-glycidyloxypropyl) trimethoxysilane-functionalized SiO2 nanoparticles, which is utilized as a protective layer and hybrid solid-state electrolyte (HSE) for stable Li-metal batteries. The presence of a dynamic exchangeable disulfide affords self-heability and recyclability, and the chemical attachment between SiO2 nanoparticles and the polymer matrix enables the homogeneous distribution of inorganic fillers and mechanical robustness. With integrated flexibility, fast segmental dynamics, and autonomous adaptability, the as-prepared CHDN-based protective layer enables superior electrochemical performance in half cells and full cells (capacity retention of 83.7% over 400 cycles for the CHDN@Li/LiFePO4 cell at 1 C). Furthermore, benefiting from intimate electrode/electrolyte interfacial contact, CHDN-based solid-state cells deliver excellent electrochemical performance (capacity retention of 89.5% over 500 cycles for the Li/HSE/LiFePO4 cell at 0.5 C). In addition, the Li/HSE/LiFePO4 pouch cell exhibits superior safety, even exposing various physical damage conditions. This work thereby provides a fresh insight into a rational design principle for dynamic network-based protective layers and solid-state electrolytes for battery applications.
Subject(s)
Neoplasms , Spine , Humans , United States , Spine/surgery , Patient Acceptance of Health Care , Patients , Retrospective StudiesABSTRACT
Objective: Large pneumothorax is a rare but dangerous complication following thoracic and lumbar tumor surgery. There is little discussion about the features of large pneumothorax following spinal tumor surgery. The purpose of this study was to analyze the characteristics of postoperative pneumothorax, identify factors related to large pneumothorax, and propose a management algorithm for prevention, diagnosis, and treatment. Methods: Included in this retrospective study were 118 patients who developed pneumothorax after receiving thoracic and lumbar tumor surgery between January 2015 and October 2021. A measurement of lung compression ≥20% on chest CT or x-ray was defined as large pneumothorax, and potential risk factors for large pneumothorax were identified by univariate analysis. Results: Spinal tumor history and intraoperative blood loss were risk factors for large pneumothorax. The common symptoms of postoperative pneumothorax were chest pain, chest tightness and dyspnea. The mean longest transverse diameter of tumors was 6.63 ± 2.4â cm. En bloc resection was performed in 70 patients, with a mean operation time of 6.9 ± 2.5â h and mean intraoperative blood loss of 1771 ± 1387â ml. The most common pathologies were chondrosarcoma, giant cell tumors of bone, and neurogenic tumors. Conclusion: During surgery, an artificial dura mater patch and a prolene suture can be used to repair the pleural and lung defects. We recommend chest CT as the preferred method for identifying postoperative pneumothorax. If a patient presents severe dyspnea, a large pneumothorax or concurrent pleural effusion, application of chest drainage is strongly recommended.
ABSTRACT
Subclassification of tumors based on molecular features may facilitate therapeutic choice and increase the response rate of cancer patients. However, the highly complex cell origin involved in osteosarcoma (OS) limits the utility of traditional bulk RNA sequencing for OS subclassification. Single-cell RNA sequencing (scRNA-seq) holds great promise for identifying cell heterogeneity. However, this technique has rarely been used in the study of tumor subclassification. By analyzing scRNA-seq data for six conventional OS and nine cancellous bone (CB) samples, we identified 29 clusters in OS and CB samples and discovered three differentiation trajectories from the cancer stem cell (CSC)-like subset, which allowed us to classify OS samples into three groups. The classification model was further examined using the TARGET dataset. Each subgroup of OS had different prognoses and possible drug sensitivities, and OS cells in the three differentiation branches showed distinct interactions with other clusters in the OS microenvironment. In addition, we verified the classification model through IHC staining in 138 OS samples, revealing a worse prognosis for Group B patients. Furthermore, we describe the novel transcriptional program of CSCs and highlight the activation of EZH2 in CSCs of OS. These findings provide a novel subclassification method based on scRNA-seq and shed new light on the molecular features of CSCs in OS and may serve as valuable references for precision treatment for and therapeutic development in OS.
ABSTRACT
Bone metastasis is a frequent complication for cancers and an important reason for the mortality in cancer patients. After surviving in bone, cancer cells can cause severe pain, life-threatening hypercalcemia, pathologic fractures, spinal cord compression, and even death. However, the underlying mechanisms of bone metastasis were not clear. The role of calcium (Ca2+) in cancer cell proliferation, migration, and invasion has been well established. Interestingly, emerging evidence indicates that Ca2+ signaling played a key role in bone metastasis, for it not only promotes cancer progression but also mediates osteoclasts and osteoblasts differentiation. Therefore, Ca2+ signaling has emerged as a novel therapeutical target for cancer bone metastasis treatments. Here, the role of Ca2+ channels and Ca2+-binding proteins including calmodulin and Ca2+-sensing receptor in bone metastasis, and the perspective of anti-cancer bone metastasis therapeutics via targeting the Ca2+ signaling pathway are summarized.
ABSTRACT
Although numerous studies on polymeric protective films to stabilize lithium (Li)-metal electrodes have been reported, the construction of self-healing polymers that enables the long-term operation of Li-metal batteries (LMBs) at relatively low temperatures has rarely been demonstrated. Herein, a highly stretchable, autonomous self-healable, and ionic-conducting polymer network (SHIPN) is synthesized as an efficient protective film for LMBs. The network backbone, synthesized from copolymerization of poly(ethylene glycol)-mono-methacrylate (PEGMMA) and 2-[[(butylamino)carbonyl]oxy]ethyl acrylate (BCOE), is chemically cross-linked via diisocyanate. With SHIPN-modified electrodes, enhanced electrochemical performance can be achieved in Li/Cu, Li/Li, and Li/LiFePO4 (Li/LFP) cells. The SHIPN@Li/LFP cell delivers a capacity retention of 85.6% after 500 cycles at 5 °C, resulting from the low-temperature self-healability of SHIPN. In full cells with a high-mass-loading LFP cathode (â¼17 mg cm-2), the capacity retention is at least 300% higher than that with a bare Li electrode. Further physical characterizations of electrodes confirm the effect of SHIPN in enhancing the interfacial stability and suppressing Li dendrite growth. Our results will provide insights into rationally designing soft and hybrid materials toward stable LMBs at different temperatures.
ABSTRACT
Therapeutics targeting osteoclasts are commonly used treatments for bone metastasis; however, whether and how osteoclasts regulate premetastatic niche and bone tropism are largely unknown. In this study, we report that osteoclast precursors (OPs) can function as a premetastatic niche component that facilitates breast cancer (BCa) bone metastasis at early stages. At the molecular level, unbiased GPCR ligand/agonist screening in BCa cells suggested that R-spondin 2 (RSPO2) and RANKL, through interaction with their receptor LGR4, promoted osteoclastic premetastatic niche formation and enhanced BCa bone metastasis. This was achieved by RSPO2/RANKL-LGR4 signal modulating the WNT inhibitor DKK1 through Gαq and ß-catenin signaling. DKK1 directly facilitated OP recruitment through suppression of its receptor LDL receptor-related protein 5 (LRP5) but not LRP6, upregulating Rnasek expression via inhibition of canonical WNT signaling. In clinical samples, RSPO2, LGR4, and DKK1 expression showed a positive correlation with BCa bone metastasis. Furthermore, soluble LGR4 extracellular domain (ECD) protein, acting as a decoy receptor for RSPO2 and RANKL, significantly alleviated bone metastasis and osteolytic lesions in a mouse bone metastasis model. These findings provide unique insights into the functional role of OPs as key components of the premetastatic niche for BCa bone metastasis and identify RSPO2/RANKL-LGR4 signaling as a promising target for inhibiting BCa bone metastasis.
Subject(s)
Bone Neoplasms/metabolism , Breast Neoplasms/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Neoplasm Proteins/metabolism , Osteoclasts/metabolism , RANK Ligand/metabolism , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , Tumor Microenvironment , Animals , Bone Neoplasms/genetics , Breast Neoplasms/genetics , Breast Neoplasms/secondary , Cell Line, Tumor , Female , Humans , Intercellular Signaling Peptides and Proteins/genetics , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Metastasis , Neoplasm Proteins/genetics , RANK Ligand/genetics , Receptors, G-Protein-Coupled/geneticsABSTRACT
Cancer metastasis, a process that primary tumor cells disseminate to secondary organs, is the most lethal and least effectively treated characteristic of human cancers. Kisspeptins are proteins encoded by the KISS1 gene that was originally described as a melanoma metastasis suppressor gene. Then, Kisspeptins were discovered as the natural ligands of the G-protein-coupled receptor 54 (GPR54) that is also called KISS1R. The KISS1/KISS1R signaling is essential to control GnRH secretion during puberty and to establish mammalian reproductive function through the hypothalamic-pituitary-gonadal (HPG) axis. Although KISS1 primarily plays a suppressive role in the metastasis progression in several cancer types, emerging evidence indicates that the physiological effect of KISS1/KISS1R in cancer metastasis is tissue context-dependent and still controversial. Here, we will discuss the epigenetic mechanism involved in the regulation of KISS1 gene expression, the context-dependent role of KISS1/KISS1R, prometastasis/anti-metastasis signaling pathways of KISS1/KISS1R, and the perspective anticancer therapeutics via targeting KISS1/KISS1R.
Subject(s)
Kisspeptins , Neoplasms , Animals , Genes, Tumor Suppressor , Humans , Kisspeptins/genetics , Kisspeptins/metabolism , Mammals/genetics , Mammals/metabolism , Neoplasms/genetics , Proteins/genetics , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Receptors, Kisspeptin-1/genetics , Signal TransductionABSTRACT
Xanthomonas citri pv. citri is the causative agent of citrus canker, one of the most devastating diseases threatening global citrus production. Here, we present the genome sequence of X. citri pv. citri strain GD82 from a formalin-fixed citrus leaf specimen showing canker lesions collected in 1982 in Guangdong Province, China. The GD82 genome consisted of 5,197,217 bp with G+C content of 64.8%, along with four circular plasmids: pXAC33 (32,377 bp), pXAC64 (63,972 bp), pXAC47 (47,810 bp), and pGD82.1 (219,560 bp). This is the oldest X. citri pv. citri genome from historical citrus canker specimens in China, which will enrich the current X. citri pv. citri genome database and facilitate genomic evolution research of X. citri pv. citri.
Subject(s)
Citrus , Formaldehyde , Plant Diseases , Plant Leaves , XanthomonasABSTRACT
The detection of multiple pesticides in food and environment is of great importance for human health and safety. In this study, the DNA backbone structure and Ag@Au nanoparticles (NPs) to construct a nano-tetrahedron with the help of the surface-enhanced Raman scattering (SERS) effect by controlling the formation of SERS hotspots and subsequently realized the simultaneous detection of multiple pesticides. The DNA aptamers corresponding to the three pesticides of profenofos, acetamiprid and carbendazim were embedded into the three edges of the DNA tetrahedral skeleton, and the tetrahedral corners were connected to modify the Ag@Au NPs with different Raman signaling molecules. When aptamers recognize the related pesticides, the DNA backbone is deformed. Then Ag@Au NPs approach to each other with SERS hotspots formed and the intensity of the Raman signal increased, realizing the detection of the pesticide content. The biosensor constructed from the SERS substrate with higher sensitivity and lower detection limit (profenofos: 0.0021 ng mL-1; acetamiprid: 0.0046 ng mL-1; carbendazim: 0.0061 ng mL-1). The practicability of this proposed method was verified by adding the recovery rate detection and the accuracy of the method was examined by the analysis of the HPLC-MS method. The proposed SERS biosensor could distinguish and detect three pesticides in food and environmental samples with high sensitivity and low detection limit that can be used in practical applications.
Subject(s)
Biosensing Techniques , Metal Nanoparticles , Pesticides , Gold , Humans , Pesticides/analysis , Silver , Spectrum Analysis, RamanABSTRACT
Breast cancer has a high prevalence in the general population and is often associated with bone metastasis. Specific therapeutic targets are missing for triple negative breast cancer (TNBC), which presents some immunogenic characteristics. Betulinic acid (BA) has been reported to have some anti-tumor properties, and its modified derivative SH-479 was demonstrated to inhibit TNBC bone metastasis. The present study aimed to investigate the effect of the BA derivative SH-479 on breast cancer and bone microenvironment. The effect of BA and its derivative SH-479 on MDA-MB-231 cell proliferation was determined with the MTS method. The cytotoxicity effect of SH-479 was evaluated using the Live and Dead assay. Cell microfilament changes were observed by F-actin staining. The effects of SH-479 on PARP protein expression and cell cycle were detected by western blotting and flow cytometry, respectively. The migratory ability of breast cancer cells treated with SH-479 was determined by migration assay. The effect of SH-479 on osteoclast differentiation induced by breast cancer cells was observed using the osteoclast differentiation assay and tartrate-resistant acid phosphatase staining. The effects of SH-479 on T lymphocytes and bone marrow-derived suppressor cells (MDSCs) in bone marrow from mice were observed by flow cytometry. The results demonstrated that SH-479 significantly inhibited the proliferation of the TNBC cell line MDA-MB-231 at lower concentrations but had no significant effect on normal cells and other types of breast cancer cells for the same concentration. Furthermore, SH-479 significantly interfered with actin microfilaments in breast cancer cells but had no effect on cell apoptosis and cell cycle. In addition, SH-479 inhibited the migratory ability of breast cancer cells and the differentiation of osteoclasts induced by breast cancer cells. In bone marrow immune microenvironment, addition of SH-479 could promote the proliferation of CD4+T lymphocytes and inhibit the proliferation of MDSCs. Taken together, the findings from this study demonstrated that SH-479 inhibited the activity and migratory ability of TNBC cells and the differentiation of osteoclasts induced by TNBC and affected the bone marrow immune microenvironment. SH-479 may therefore inhibit breast cancer metastasis to bones, indicating that SH-479 may be considered as a promising drug to inhibit bone metastasis in patients with breast cancer.
ABSTRACT
Chlorothalonil (CHL), imidacloprid (IMI) and oxyfluorfen (OXY) are commonly used in combination to increase crop yield. However, these three pesticides are toxic to aquatic organisms and do not easily degrade. In this study, a surface-enhanced Raman scattering-based lateral flow assay (SERS-LFA) test strip was prepared by combining antibodies with SERS nanotags, and then competitive immune binding was used to detect the three pesticides simultaneously. Moreover, the two-way binding effect of ssDNA-streptavidin bound to Ag4-NTP@AuNPs and Ag4-NTP@AuNPs with antibodies was used to further amplify the detection signal. Under the optimal conditions, the SERS-LFA test strips exhibited high sensitivity, a low detection limit, short detection time, high specificity and low cost. Furthermore, the detection range was within the values prescribed by international detection standards. By measuring the intensity of the SERS signal on the test line of the paper strip, accurate quantitative analysis was achieved. The practical application of the proposed system was demonstrated by simultaneous detection of CHL, IMI and OXY in environmental and food samples with satisfactory results.
Subject(s)
Biosensing Techniques , Metal Nanoparticles , Pesticides , Gold , Spectrum Analysis, RamanABSTRACT
Rheumatoid arthritis (RA) is an autoimmune disease mainly characterized as chronic inflammation of joint. Both genetic and environmental factors play important roles in RA progression. G protein-coupled receptor 54 (GPR54) and Kisspeptins (KPs), the natural GRP54 ligands encoded by Kiss-1 gene are known to play important roles in immune regulation but the precise role of KP-10/GPR54 in RA remains elusive. Kiss1/Gpr54 expression was determined by immunohistochemistry on protein and real-time PCR on RNA from isolated RA-patient synovial tissue and PBMC. Collagen-induced arthritis (CIA) mouse models were used to investigate the effect of KP-10/Gpr54 on the rheumatic arthritis severity in the mice. The signaling pathway involved in KP-10/GPR54 was assessed by western blot and immunofluorescence.In the present study, we demonstrated that GPR54 upregulation in bone marrow-derived macrophages (BMDM) was associated with the severity of RA. In addition, Gpr54-/- increased the inflammatory cytokines induced by lipopolysaccharide (LPS) in BMDM and diseased severity of CIA (n = 10), while KP-10 reduced the LPS-induced inflammatory cytokines in vitro and ameliorated the CIA symptoms in vivo. Furthermore, we demonstrated that KP-10/GPR54 binds to PP2A-C to suppressed LPS induced NF-κB and MAPK signaling in BMDM. All these findings suggest that KP-10/GPR54 may be a novel therapeutic target for the diagnosis and treatment of RA.
Subject(s)
Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/drug therapy , Kisspeptins/therapeutic use , Osteoarthritis/genetics , Receptors, Kisspeptin-1/genetics , Rheumatic Fever/genetics , Animals , Ankle Joint/diagnostic imaging , Ankle Joint/drug effects , Ankle Joint/pathology , Anti-Inflammatory Agents/pharmacology , Arthritis, Experimental/diagnostic imaging , Arthritis, Experimental/immunology , Arthritis, Experimental/pathology , Cells, Cultured , Cytokines/genetics , Humans , Kisspeptins/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/immunology , Mice, Inbred DBA , Mice, Knockout , Mitogen-Activated Protein Kinases/immunology , NF-kappa B/immunology , Osteoarthritis/immunology , Receptors, Kisspeptin-1/immunology , Rheumatic Fever/immunology , Signal Transduction/drug effects , Synovial Membrane/drug effects , Synovial Membrane/immunology , Up-Regulation/drug effectsABSTRACT
Spinal schwannoma is the most common primary spinal tumor but its genomic landscape and underlying mechanism driving its initiation remain elusive. The aim of the present study was to gain further insights into the molecular mechanisms of this kind of tumor through whole genome sequencing of nine spinal schwannomas and paired blood samples. The results showed that ATM, CHD4, FAT1, KMT2D, MED12, NF2, and SUFU were the most frequently mutated cancer-related genes. In addition, the somatic copy number alterations (CNA) was potentially associated with spinal schwannoma, among which NF2 was found to be frequently deleted in schwannoma samples. Only a few genes were located within the amplified regions. In contrast, the deleted regions in 15q15.1 and 7q36.1 contained most of these genes. With respect to tumorigenesis, NF2 had the highest variant allele frequency (VAF) than other genes, and homozygous deletion was observed in NF1, NF2, and CDKN2C. Pathway-level analysis suggested that Hippo signaling pathway may be a critical pathway controlling the initiation of spinal schwannoma. Collectively, this systematic analysis of DNA sequencing data revealed that some key genes including NF1, NF2, and CDKN2C and Hippo signaling pathway were associated with spinal schwannoma, which may help improve our understanding about the genomic landscape of spinal schwannoma.